Reports on the relationship of circulating levels of adiponectin and leptin to incident post-menopausal breast cancer are contradictory [27,43,44,45,46,47,48], and the association of breast cancer recurrence and survival with circulating concentrations of these adipokines is equally mixed [4,5,6,7,8]. Here, ADIPOQ is linked to breast carcinoma.